Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients

Clinical Nephrology

Volumn 60, Issue 2, 2003, Pages 119-124

  Engelen, W ^a   Verpooten, G A ^a   Van der Planken, M ^a   Helbert, M F ^a   Bosmans, J L ^a   De Broe, M E ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anemia; Case report; Kidney transplantation; Mycophenolate mofetil; Red cell aplasia

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; IRON; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT ERYTHROPOIETIN; THYMOCYTE ANTIBODY;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG SPECIFICITY; DRUG USE; DRUG WITHDRAWAL; ERYTHROCYTE APLASIA; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE; MALE; PANCYTOPENIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; SUPPLEMENTATION; VIRUS INFECTION;

EID: 0042532055     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp60119     Document Type: Article

References (18)

1. Ahsan N, Holman MJ, Gocke CD, Groff JA, Yang HC 1997 Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transplant 11: 265-270
2. Allison AC, Eugui EM 1993 Immunosuppressive and other effects of mycophenolic acid and ester prodrug, mycophenolate mofetil. Immunol Rev 136: 5-28
3. Allison AC, Eugui EM 1993 Mycophenolate mofetil, a rationally designed immunosuppressive drug. Clin Transplant 7: 96-112
4. Allison AC, Eugui EM 1994 Preferential suppression of lymphocyte proliferation by mycophenolate acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc 26: 3205-3210
5. Allison AC, Eugui EM 1996 Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10: 77-84
6. Arbeiter K, Greenbaum L, Balzar E, Müller T, Hofmeister F, Bidmon B, Aufricht Ch 2000 Reproducible erythroid aplasia caused by mycophenolate mofetil. Pediatr Nephrol 14: 195-197
7. Butani L, Palmir J, Polinsky M, Baluarte HJ 1999 Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection. Transplantation 68: 83-86
8. Carl S, Wiesel M and the European Mycophenolate Mofetil Cooperative Study Group 1997 Mycophenolate mofetil (Cellcept) in renal transplantation: the European Experience. Transplant Proc 29: 2932-2935
9. Kaplan B, Gruber SA, Nallamathiou R, Katz SM, Shaw LM 1998 Decreased protein binding of mycophenolic acid associated with leucopenia in a pancreas transplant recipient with renal failure. Transplantation 65: 1127-1129
10. MacPhee IAM, Spreafico S, Bewick M, Davis C, Eastwood JB, Johnston A, Lee T, Holt DW 2000 Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure. Kidney Int 57: 1164-1168
11. Mathias RS 1997 Chronic anemia as a complication of parvovirus B19 infection in a pediatric kidney transplant patient. Pediatr Nephrol 11: 355-357
12. Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC 1990 Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B cell purine synthesis. Transplant Proc 22: 1659-1662
13. Natsumeda Y, Carr SF 1993 Human type I and II IMP dehydrogenase as drug targets. Ann NY Acad Sci 696: 88-93
14. Sollinger HW for the US Renal Transplant Mycophenolate Mofetil Study Group 1995 Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60: 225-232
15. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group 1996 A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61: 1029-1037
16. US Renal Transplant Mycophenolate Mofetil Study Group 1999 Mycophenolate mofetil in cadaveric renal transplantation. Am J Kidney Dis 34: 296-303
17. Van Besouw NM, Van Der Mast BJ, Smak Gregoor PJH, Hesse CJ, Ijzermans JNM, Van Gelder T, Weimar W 1999 Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels. Nephrol Dial Transplant 14: 2710-2713
18. Ysebaert DK, De Greef KE, Vercauteren SR, Kockx M, Verpooten G, De Broe ME 2003 Effect of immunosuppression on damage, leucocyte infiltration and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int submitted